Inscripta Raises $55.5M For Gene Editing Tools
Pleasanton, California- and Boulder, Colorado-based Inscripta has received $55.5M in a Series C funding, the company said this week, led by Merieux Developpement and Paladin Capital Group, and also included Venrock, Foresite, Spruce, and NanoDimension. Inscripta, which develops gene editing tools, said the new funding comes in preparation for expansion of its platform, and commercial launch. Kevin Ness is CEO of Inscripta.
posted on Thursday, March 1, 2018 (Link to more information)
Related companies:
Inscripta
Related stories:
> Applied StemCell Picks Up $19M For Gene Editing Efforts
> VSCO Sees $40M For Photo Editing Tools
> WeVideo Raises $19.1M For Online Video Editing
> Photobucket Taps FotoFlexer For Image Editing
> Sangamo Therapeutics Acquires TxCell
silicontap.com Home